E-Mail Updates

Click here to join
our Electronic Communications.

Financial Information

ASX Filing.

Date Price sens. Headline pages PDF
21/08/2018 ! Appendix 4E & 2018 Full Year Statutory Accounts 82 PDF
16/08/2018   Immutep to present at BioCentury NewsMakers conference 2 PDF
07/08/2018 ! Immutep secures Canadian patent grant for IMP731 antibody 2 PDF
07/08/2018 ! TACTI-mel Patient Recruitment Complete & Operational Update 3 PDF
31/07/2018 ! Immutep receives IND approval from US FDA for IMP321 2 PDF
30/07/2018 ! Appendix 4C - quarterly 5 PDF
02/07/2018 ! Immutep submits IND application with FDA 2 PDF
19/06/2018   Investor Update 13 PDF
19/06/2018 ! Mid-point of patient enrolment reached in AIPAC trial 2 PDF
04/06/2018   Immutep Poster Presentations at ASCO 2 PDF
30/05/2018 ! Webcast slides for TACTI-mel clinical trial data 25 PDF
30/05/2018 ! New Data from Ongoing TACTI-mel Study 2 PDF
25/05/2018   3rd Annual Advances in Immuno-Oncology Congress Presentation 37 PDF
17/05/2018   Webcast to discuss interim results from TACTI-mel 3 PDF
15/05/2018   Response to ASX Price Query 3 PDF
04/05/2018   Immutep to present at ASCO 2 PDF
23/04/2018   Appendix 4C 5 PDF
13/04/2018   Appendix 3B 13 PDF
13/04/2018   Completion of Share Purchase Plan 2 PDF
03/04/2018 ! Operational Update 2 PDF
23/03/2018   Cambridge Healthtech Institute's I-O Summit Presentation 2 PDF
22/03/2018   Patient dosing commences in additional TACTI-mel cohor 2 PDF
19/03/2018   Becoming a substantial holder from AEF 3 PDF
14/03/2018   Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) 1 PDF
14/03/2018   Appendix 3B and Cleansing Notice 14 PDF
13/03/2018   Share Purchase Plan Offer Documents 22 PDF
12/03/2018 ! Immutep raises A$6.85M through institutional placement 2 PDF
06/03/2018 ! US patent grant for IMP701 antibody 2 PDF
05/03/2018 ! Immutep receives A$686,704 R&D Tax Incentive 1 PDF
22/02/2018   Half Yearly Report and Accounts 25 PDF
09/02/2018 ! Outcome of DSMB Safety Review & Extension of TACTI-mel 2 PDF
01/02/2018 ! Immutep receives USD1M milestone payment from EOC 2 PDF
22/01/2018 ! Appendix 4C - quarterly 5 PDF
22/12/2017   Change of Director's Interest Notice - Russell Howard 5 PDF
21/12/2017   Investor Update 11 PDF
04/12/2017   Change of Director's Interest Notice - Mr Voigt 4 PDF
04/12/2017   Change of Director's Interest Notice - Mr Chamberlain 3 PDF
04/12/2017   Appendix 3B 19 PDF
28/11/2017   Prima BioMed company name changed to Immutep 1 PDF
22/11/2017   Final Director's Interest Notice 2 PDF
22/11/2017   Final Director's Interest Notice 2 PDF
22/11/2017 ! European patent grant for IMP321 in cancer 2 PDF
20/11/2017   Prima changes its name to Immutep Ltd 2 PDF
17/11/2017   Results of Meeting 2 PDF
17/11/2017   2017 AGM CEO Presentation 26 PDF
17/11/2017   2017 AGM Chairman's Address 3 PDF
15/11/2017   Pre-IND meeting with the FDA 2 PDF
09/11/2017   SITC 2017 Poster Presentation 3 PDF
01/11/2017   World Immunotherapy Congress 2017 Presentation 2 PDF
20/10/2017   Warrants Cleansing Prospectuses 98 PDF
20/10/2017   Dr Triebel presenting at World Immunotherapy Congress 2 PDF

 

SEC Filing.

Date Filing Description Link
2018-08-17 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-251021 (34 Act) Size: 21 KB
PDF
2018-08-08 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-241616 (34 Act) Size: 56 KB 
PDF-2
2018-08-08 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-241616 (34 Act) Size: 56 KB
PDF-1
2018-08-01 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-233634 (34 Act) Size: 24 KB
PDF
2018-07-31 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-232248 (34 Act) Size: 108 KB
PDF
2018-07-03 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-211709 (34 Act) Size: 35 KB
PDF
2018-06-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-197123 (34 Act) Size: 3 MB
PDF-1
PDF-2
2018-06-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-183678 (34 Act) Size: 34 KB
PDF
2018-05-31 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-179361 (34 Act) Size: 10 MB
PDF-1 PDF-2
2018-05-30 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-177481 (34 Act) Size: 9 MB
PDF
2018-05-18 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-166845 (34 Act) Size: 33 KB
PDF
2018-05-07 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-153820 (34 Act) Size: 32 KB
PDF
2018-04-23 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-131968 (34 Act) Size: 117 KB
PDF
2018-04-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-117066 (34 Act) Size: 21 KB
PDF
2018-04-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-117059 (34 Act) Size: 115 KB
PDF
2018-04-04 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-106513 (34 Act) Size: 29 KB
PDF
2018-03-23 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-092333 (34 Act) Size: 40 KB
PDF
2018-03-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-088365 (34 Act) Size: 48 KB
PDF
2018-03-16 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-084753 (34 Act) Size: 131 KB
PDF
2018-03-16 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-084753 (34 Act) Size: 131 KB
PDF
2018-03-16 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-084749 (34 Act) Size: 666 KB
PDF
2018-03-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-079559 (34 Act) Size: 46 KB
PDF
2018-03-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-079559 (34 Act) Size: 46 KB
PDF
2018-03-07 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-072339 (34 Act) Size: 32 KB
PDF
2018-03-06 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-070788 (34 Act) Size: 20 KB
PDF
2018-02-23 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-054417 (34 Act) Size: 468 KB
PDF
2018-02-09 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-037078 (34 Act) Size: 22 KB
PDF
2018-02-02 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-029526 (34 Act) Size: 23 KB
PDF
2018-01-23 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-016260 (34 Act) Size: 110 KB
PDF
2017-12-26 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-17-378237 (34 Act) Size: 64 KB
PDF
2017-12-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-17-367609 (34 Act) Size: 31 KB
PDF
2017-12-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-17-360727 (34 Act) Size: 253 KB
PDF
2017-12-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-17-360727 (34 Act) Size: 253 KB
PDF
2017-12-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-17-360727 (34 Act) Size: 253 KB
PDF
2017-12-01 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-357745 (34 Act) Size: 393 KB PDF
2017-12-01 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-357745 (34 Act) Size: 393 KB PDF
2017-11-24 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-351219 (34 Act) Size: 45 KB PDF
2017-11-24 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-351219 (34 Act) Size: 45 KB PDF
2017-11-22 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-349885 (34 Act) Size: 35 KB PDF
2017-11-21 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-348286 (34 Act) Size: 35 KB PDF
2017-11-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-347626 (34 Act) Size: 6 MB PDF
2017-11-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-347626 (34 Act) Size: 6 MB PDF
2017-11-20 6-K Documents Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-347625 (34 Act) Size: 51 KB PDF
2017-11-16 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-344407 (34 Act) Size: 31 KB PDF
2017-11-09 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-339045 (34 Act) Size: 35 KB PDF
2017-11-01 EFFECT Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-328236 (34 Act) Size: 34 KB PDF
2017-10-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-315493 (34 Act) Size: 53 KB PDF
2017-10-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-315468 (34 Act) Size: 337 KB PDF
2017-10-19 F-3 Registration statement by foreign private issuers Acc-no: 0001193125-17-313995 (33 Act) Size: 505 KB PDF